172 related articles for article (PubMed ID: 9702705)
1. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways.
Kresse M; Wagner S; Pfefferer D; Lawaczeck R; Elste V; Semmler W
Magn Reson Med; 1998 Aug; 40(2):236-42. PubMed ID: 9702705
[TBL] [Abstract][Full Text] [Related]
2. Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide.
Schäfer R; Kehlbach R; Wiskirchen J; Bantleon R; Pintaske J; Brehm BR; Gerber A; Wolburg H; Claussen CD; Northoff H
Radiology; 2007 Aug; 244(2):514-23. PubMed ID: 17562811
[TBL] [Abstract][Full Text] [Related]
3. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison.
Sun R; Dittrich J; Le-Huu M; Mueller MM; Bedke J; Kartenbeck J; Lehmann WD; Krueger R; Bock M; Huss R; Seliger C; Gröne HJ; Misselwitz B; Semmler W; Kiessling F
Invest Radiol; 2005 Aug; 40(8):504-13. PubMed ID: 16024988
[TBL] [Abstract][Full Text] [Related]
4. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
5. [MRI monitoring ultra-small superparamagnetic iron oxide (USPIO) particle labeling C6 rat glioma cells].
Zhang GX; Li YJ; Zhang F; Zhao JL; Li KA; Hu YS
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):228-32. PubMed ID: 17425864
[TBL] [Abstract][Full Text] [Related]
6. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging.
Corot C; Petry KG; Trivedi R; Saleh A; Jonkmanns C; Le Bas JF; Blezer E; Rausch M; Brochet B; Foster-Gareau P; Balériaux D; Gaillard S; Dousset V
Invest Radiol; 2004 Oct; 39(10):619-25. PubMed ID: 15377941
[TBL] [Abstract][Full Text] [Related]
7. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model.
Turetschek K; Roberts TP; Floyd E; Preda A; Novikov V; Shames DM; Carter WO; Brasch RC
J Magn Reson Imaging; 2001 Jun; 13(6):882-8. PubMed ID: 11382948
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging.
Senéterre E; Weissleder R; Jaramillo D; Reimer P; Lee AS; Brady TJ; Wittenberg J
Radiology; 1991 May; 179(2):529-33. PubMed ID: 2014305
[TBL] [Abstract][Full Text] [Related]
9. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents.
Reimer P; Kwong KK; Weisskoff R; Cohen MS; Brady TJ; Weissleder R
J Magn Reson Imaging; 1992; 2(2):177-81. PubMed ID: 1562768
[TBL] [Abstract][Full Text] [Related]
10. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.
Turetschek K; Huber S; Floyd E; Helbich T; Roberts TP; Shames DM; Tarlo KS; Wendland MF; Brasch RC
Radiology; 2001 Feb; 218(2):562-9. PubMed ID: 11161179
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol.
Corot C; Violas X; Robert P; Gagneur G; Port M
Invest Radiol; 2003 Jun; 38(6):311-9. PubMed ID: 12908698
[TBL] [Abstract][Full Text] [Related]
12. Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia.
Schroeter M; Saleh A; Wiedermann D; Hoehn M; Jander S
Magn Reson Med; 2004 Aug; 52(2):403-6. PubMed ID: 15282824
[TBL] [Abstract][Full Text] [Related]
13. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
14. Ultrasmall superparamagnetic particles of iron oxide (USPIO) MR imaging of infarcted myocardium in pigs.
Kroft LJ; Doornbos J; van der Geest RJ; van der Laarse A; van der Meulen H; de Roos A
Magn Reson Imaging; 1998 Sep; 16(7):755-63. PubMed ID: 9811141
[TBL] [Abstract][Full Text] [Related]
15. Extra- and intracellular accumulation of ultrasmall superparamagnetic iron oxides (USPIO) in experimentally induced abscesses of the peripheral soft tissues and their effects on magnetic resonance imaging.
Gellissen J; Axmann Ch; Prescher A; Bohndorf K; Lodemann KP
Magn Reson Imaging; 1999 May; 17(4):557-67. PubMed ID: 10231182
[TBL] [Abstract][Full Text] [Related]
16. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors.
Taschner CA; Wetzel SG; Tolnay M; Froehlich J; Merlo A; Radue EW
AJR Am J Roentgenol; 2005 Dec; 185(6):1477-86. PubMed ID: 16304001
[TBL] [Abstract][Full Text] [Related]
18. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
[TBL] [Abstract][Full Text] [Related]
19. Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: an MR finding with potential benefits in T staging of uterine neoplasms.
Laghi A; Paolantonio P; Panebianco V; Miglio C; Iafrate F; Di Tondo U; Passariello R
Invest Radiol; 2004 Nov; 39(11):666-70. PubMed ID: 15486527
[TBL] [Abstract][Full Text] [Related]
20. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.
Simon GH; Bauer J; Saborovski O; Fu Y; Corot C; Wendland MF; Daldrup-Link HE
Eur Radiol; 2006 Mar; 16(3):738-45. PubMed ID: 16308692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
